| Literature DB >> 31771644 |
Sasipaka Sindhusen1, Kumutnart Chanprapaph1, Suthinee Rutnin2.
Abstract
BACKGROUND: Linear cutaneous lupus erythematosus (LE) is an unusual form of LE-specific cutaneous condition, occurring in children and young adults. Due to its rarity, the diagnosis of linear cutaneous LE can be difficult and facial lesions can resemble linear morphea or en coup de sabre. Differential diagnosis of similar conditions along the lines of Blaschko must be differentiated from linear LE. CASEEntities:
Keywords: Blaschko line; Discoid lupus erythematosus; En coup de sabre; Linear lupus erythematosus; Linear morphea
Mesh:
Year: 2019 PMID: 31771644 PMCID: PMC6880516 DOI: 10.1186/s13256-019-2249-7
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Fig. 1Linear erythematous to purplish atrophic patch on the forehead
Fig. 2Dermatoscopy demonstrated structureless whitish areas (asterisk), follicular keratotic plugs (arrow), telangiectatic vessels and brown to grayish pigmentation (original magnification × 50)
Fig. 3Histopathology of linear discoid lupus erythematosus (a) superficial and deep perivascular and periadnexal lymphocytic infiltrate (haematoxylin and eosin stain, original magnification × 40) (b) epidermal atrophy, hydropic degeneration of the basal cell layer, numerous melanophages, and telangiectasia (haematoxylin and eosin stain, original magnification × 400) (c) follicular interface change with follicular hyperkeratosis (haematoxylin and eosin stain, original magnification × 400)
Fig. 4Direct immunofluorescence showed homogenous granular deposition of IgM and few cytoid bodies along the basement membrane (a) and follicular epithelium (b) (original magnification × 400)
Summary of previous reported cases of adult-onset linear cutaneous lupus erythematosus on the forehead [7]
| No. | Sex | Age of onset | Duration | Location | Pathological diagnosis | DIF | ANA | Other autoantibodies | Progression to SLE | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 29 y | 3 y | Forehead | CLE | +Granular IgM | – | NA | No | TC, HCQ |
| 2 | F | 21 y | Few m | Forehead, scalp | LET | NA | 9 y later: +ANA | 9 y later: +anti-dsDNA, +RF | Yes | ILC 9 y later: IC, OC, CTX, HCQ |
| 3 | M | 49 y | 1 y | Forehead, inner eye angle, right lateral aspect of nose | CCLE | +Band-like IgG, IgM, IgA, C3 | – | NA | No | HCQ |
| 4 | M | 21 y | 1 y | Forehead, left supraorbital and infraorbital area, left angle of mouth | CLE | + | – | +Anti-SSA, +anti-SSB | No | HCQ, TC, TCI |
| 5 | M | 33 y | 1 y | Forehead | CCLE, Scl | +Granular IgM | – | -Anti-RNP, -anti-NCS, -anti-dsDNA | No | CQ, TC, TCI |
| 6 | M | 33 y | 2 m | Forehead, left eyelid, nose | CLE | NA | – | NA | No | HCQ, TC |
| 7 | F | 24 y | 2 y | Forehead, scalp | LEP | +Granular IgG | +ANA | +Anti-SSA -anti-dsDNA, -anti-ssDNA, -anti-Sm, -anti-SSB | No | OC |
| 8 | M | 42 y | 1 y | Forehead, right upper eyelid | LET | +Granular IgM, C3 | – | NA | No | OC, HCQ |
| 9 | F | 24 y | 8 y | Forehead, scalp, left cheek | DLE, Scl | NA | NA | NA | No | OC, CQ, TC, TCI |
Abbreviations: ANA, anti-nuclear antibodies; anti-dsDNA, anti-double stranded DNA; anti-NCS, antinucleosome; anti-RNP, anti-ribonucleoprotein; anti-Sm, anti-Smith; anti-ssDNA, anti-single stranded DNA; C3, complement C3; CCLE, chronic cutaneous lupus erythematosus; CLE, cutaneous lupus erythematosus; CQ, chloroquine; CTX, cyclophosphamide; DIF, direct immunofluorescence; DLE, discoid lupus erythematosus; F, female; HCQ, hydroxychloroquine; IC, Intravenous corticosteroid; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; ILC, intralesional injection of corticosteroid; LEP, lupus erythematosus panniculitis; LET, lupus erythematosus tumid; M, male; m, month; NA, Not available; No., number; OC, oral corticosteroid; RF, rheumatoid factor; Scl, scleroderma; SLE, systemic lupus erythematosus; TC, topical corticosteroid; TCI, topical calcineurin inhibitors; y, year